Abstract:The CD44 molecule is a widely distributed cell surface receptor for the extracellular matrix glycosaminoglycan hyaluronan. The ligand-binding site which is located in the membrane distal portion of the molecule encompasses a region of approximately 100 amino acids termed the Link domain, a structural unit that is conserved among members of the Hyaladherin superfamily which includes cartilage link protein, aggrecan, and tumor necrosis factor-stimulated gene-6 (TSG-6). In contrast to these other Hyaladherins, however, the ligand-binding domain of CD44 appears to extend beyond the Link domain to involve additional basic residues located toward the membrane proximal region. Furthermore, recent molecular modeling studies indicate that within the CD44 Link domain itself, the spatial arrangement of critical residues involved in HA binding is likely to differ significantly from the prototypic TSG-6 Link module. In order to obtain material to solve the CD44 solution structure we have developed an optimized method for the expression and purification of functionally active CD44 ectodomains encompassing both the Link module and the additional downstream HA-binding residues in Escherichia coli. Here we describe the details of the method which involves solubilization of recombinant CD44 from inclusion bodies in 8 M urea, followed by refolding and purification of intact monomers using size-exclusion and reverse-phase chromatography. We show the method yields CD44 molecules that (1) retain reactivity with a panel of conformation-sensitive antibodies, (2) possess similar hyaluronan-binding characteristics to authentically folded CD44 molecules expressed in eukaryotic cells, and (3) display one-dimensional NMR spectra that indicate the presence of a single conformational species. This method should enable sufficient amounts of functional CD44 Link module to be produced for comprehensive structural analyses by multidimensional NMR spectroscopy.

Identification, expression, and purification of a unique stable domain from human HSPC144 protein.

Characterization of a functional hyaluronan-binding domain from the human CD44 molecule expressed in Escherichia coli

The Coiled-Coil Neck Domain of Human Pulmonary Surfactant Protein D Drives Trimerization and Stabilization of Thioredoxin, a Heterologous Non-Collagenous Protein.

Expression and Purification of Human Wwp2 Hect Domain in Escherichia Coli

Expression, Purification and Crystallization of Human FCHo1 Μhd Domain

Cloning and Characterization of DULP, a Novel Ubiquitin-Like Molecule from Human Dendritic Cells.

[Preliminary structural and functional study on a novel gene HSPCSET].

Purification and identification of human CD40 extracellular domain expressed in Escherichia coli

Refined Purification of Large Amounts of Rat Cvhsp/hspb7 and Partial Biological Characterization in Vitro.

Solution Structure of the Human HSPC280 Protein.

Cloning and Identification of A Novel Ubiquitin-Like Protein, Bmsc-Ubp, from Human Bone Marrow Stromal Cells

A Preliminary Study on Functional Domains of Small Heat Shock Protein Hsp16.3 *

Isolation and Identification of a Novel Cdna That Encodes Human Yrdc Protein

Determining the DUF55-domain structure of human thymocyte nuclear protein 1 from crystals partially twinned by tetartohedry.

Identification of Dep Domain-Containing Proteins by A Machine Learning Method and Experimental Analysis of Their Expression in Human Hcc Tissues

Purification,Crystallization and Crystallographic Analysis of the Pelota C-terminal Domain from Human

Soluble expression and purification of human 8-defensin DEFB136 in<i> Escherichia</i><i> coli</i> and identification of its bioactivity

Hspc070, A Novel Ring Finger Protein Gene, Is Preferentially Expressed In Myelocytic Lineage And Involved In G-Protein Mediated Signal Transduction.

Solution structure of the human HSPC280 protein: Solution Structure of HSPC280

Solution structure of the ubiquitin-like domain of human DC-UbP from dendritic cells.

Soluble Fusion Expression and Characterization of Human Beta-Defensin 3 Using a Novel Approach.